Molecular Cytogenetics Market Rides On Rising Genetic Disorder And Cancer Cases: The Driving Engine Behind Molecular Cytogenetics Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Molecular Cytogenetics Market Size Growth Forecast: What to Expect by 2025?
In recent times, the molecular cytogenetics market has witnessed significant growth. This market is expected to increase from $2.85 billion in 2024 to $3.1 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. The growth during the historical period can be credited to the increasing incidence of genetic disorders and cancer, the burgeoning demand for personalized medicine, and advancements in life sciences research and development. Other contributing factors include clinical applications for prenatal and postnatal diagnoses, and worldwide initiatives in genomic medicine.

How Will the Molecular Cytogenetics Market Size Evolve and Grow by 2029?
The market size of molecular cytogenetics is projected to witness swift expansion in the upcoming years. It is estimated to increase to $4.62 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. Various factors contributing to the growth during the forecasted timeframe include advancements in next-generation sequencing (NGS), rising spotlight on liquid biopsies, increasing use in cancer research, wider applicability in diagnosing infectious diseases and the exponential growth of genetic testing services. Key trends expected to develop within this period include the use of next-generation sequencing (NGS) in cytogenetics, the advent of automation and high-throughput screening, advances in fluorescence in situ hybridization (fish), increased usage in cancer diagnostics and single-cell analysis.

View the full report here:
https://www.thebusinessresearchcompany.com/report/molecular-cytogenetics-global-market-report

What Drivers Are Propelling the Growth of Molecular Cytogenetics Market Forward?
The rise in genetic disorders and cancer is anticipated to propel the molecular cytogenetics market's expansion. Cancer is a condition where the body's cells multiply uncontrollably and metastasize to different body parts. The study of cytogenetics involves examining tissue and blood samples for chromosomal changes such as damage, absence, or rearrangements. These chromosomal changes can indicate genetic diseases, conditions, or certain types of cancer. As a result, the escalating occurrences of genetic disorders and cancer could stimulate market growth. As per the American Cancer Society, a voluntary health organization in the US, it is projected that by 2040, there will be an astounding 27.5 million new cancer cases and 16.3 million related deaths globally. Furthermore, in 2022, there were 1,918,030 new cases and 609,360 fatalities due to cancer in the United States alone, with around 350 deaths each day caused by lung cancer. Consequently, the climbing incidences of genetic disorders and cancer are fueling the molecular cytogenetics market's enlargement.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10096&type=smp

What Are the Key Trends Driving Molecular Cytogenetics Market Growth?
Leading entities in the molecular cytogenetics market are prioritizing the launch of sophisticated solutions like cytogenetic diagnostics to improve the accuracy of diagnostics. The term cytogenetic diagnostics is used to describe the evaluation of the structure and attributes of chromosomes to diagnose genetic disorders, chromosomal anomalies, and other similar conditions, leveraging technologies like karyotyping and fluorescence in situ hybridization (FISH). As a case in point, in July 2023, CCMB (Centre for Cellular and Molecular Biology), a research institute based in India, set in motion optical genome mapping. This is an advanced form of genetic testing. This cutting-edge technology bolsters genetic diagnostics by allowing genome analyses at a high resolution, which is key in detecting structural changes in DNA potentially linked to a variety of genetic disorders.

What Are the Key Segments in the Molecular Cytogenetics Market?
The molecular cytogenetics market covered in this report is segmented -

1) By Product: Instruments, Kits And Reagents, Software, Services, Consumables Or Accessories
2) By Technology: Comparative Genomic Hybridization, Fluorescence In Situ Hybridization, Immunohistochemistry, Karyotyping, Other Technologies
3) By Application: Genetic Disorders, Cancer, Personalized Medicines, Other Applications
4) By End-User: Clinical And Research Laboratories, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Other End-Users

Subsegments:
1) By Instruments: Fluorescence In Situ Hybridization (FISH) Systems, Microarray Platforms, Next-Generation Sequencing (NGS) Instruments, Chromatography Systems, Imaging Systems
2) By Kits And Reagents: DNA Extraction Kits, RNA Isolation Kits, PCR Kits, Hybridization Kits, Staining Kits
3) By Software: Data Analysis Software, Image Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Reporting Software
4) By Services: Custom Research Services, Technical Support Services, Consulting Services, Training Services, Quality Control Services
5) By Consumables Or Accessories: Pipettes And Tips, Reagent Plates, Glass Slides And Coverslips, Sample Storage Containers, Assay Plates

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10096&type=smp

Who Are the Key Players Shaping the Molecular Cytogenetics Market's Competitive Landscape?
Major companies operating in the molecular cytogenetics market include Abbott Laboratories, Agilent Technologies Inc, Applied Spectral Imaging, CytoTest Inc, Danaher Corporation, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Oxford Gene Technology Limited, Affymetrix Inc, NeoGenomics Laboratories Inc, Quest Diagnostics, F. Hoffmann-La Roche AG, Bi Biological industries, Cytognomix Inc, Empire Genomics LLC., Genial Genetic Solutions Ltd., BioChain Institute Inc., BioGenex Laboratories Inc., Bio-Techne Corporation, Cytocell Ltd., Kreatech Diagnostics B.V., Leica Biosystems Nussloch GmbH, MetaSystems Group Holding GmbH, MolecularMD Corporation, Natera Inc., Opko Health Inc., PathGroup Inc., Roche Diagnostics Corporation, SciGene Corporation, SkylineDx B.V.

What Geographic Markets Are Powering Growth in the Molecular Cytogenetics Market?
North America was the largest region in the molecular cytogenetics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global molecular cytogenetics market report during the forecast period. The regions covered in the molecular cytogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10096

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.